Title:
TAZAROTENE WITH LOW DIMER IMPURITY FOR TREATING ACNE OR PSORIASIS
Document Type and Number:
WIPO Patent Application WO/2015/107542
Kind Code:
A3
Abstract:
The present invention relates to a method of treating acne or psoriasis by topically administering Tazarotene substantially free of dimer impurity of formula 4,4-dimethyl-6-[4-(4,4-dimethylthiochroman-6-yl)-buta-1,3-diynyl]-thiochroman.
Inventors:
THENNATI RAJAMANNAR (IN)
REHANI RAJEEV BUDHDEV (IN)
VAGHELA MUKESH NATHALAL (IN)
PANDYA RASHMINKUMAR RAMESHCHANDRA (IN)
REHANI RAJEEV BUDHDEV (IN)
VAGHELA MUKESH NATHALAL (IN)
PANDYA RASHMINKUMAR RAMESHCHANDRA (IN)
Application Number:
PCT/IN2014/000776
Publication Date:
June 02, 2016
Filing Date:
December 15, 2014
Export Citation:
Assignee:
SUN PHARMACEUTICAL IND LTD (IN)
International Classes:
C07D409/06; A61K31/4436; C07D335/02
Domestic Patent References:
WO2009116075A2 | 2009-09-24 | |||
WO2006040644A2 | 2006-04-20 |
Download PDF:
Previous Patent: OXIMINO DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA
Next Patent: A NASAL SPLINT AND A METHOD OF FIXING THE NASAL SPLINT IN A NOSE
Next Patent: A NASAL SPLINT AND A METHOD OF FIXING THE NASAL SPLINT IN A NOSE